Risk factors for actinic keratosis in eight European centres: A case-control study

British Journal of Dermatology

Volumn 167, Issue SUPPL. 2, 2012, Pages 36-42

  Traianou, A ^a   Ulrich, M ^b   Apalla, Z ^a   De Vries, E ^c   Bakirtzi, K ^a   Kalabalikis, D ^a   Ferrandiz, L ^d   Ruiz De Casas, A ^d   Moreno Ramirez, D ^d   Sotiriadis, D ^a   Ioannides, D ^a   Aquilina, S ^e   Apap, C ^e   Micallef, R ^f   Scerri, L ^f   Pitkanen S ^g   Saksela, O ^g   Altsitsiadis, E ^b,k   Hinrichs, B ^b   Magnoni, C ^h   Fiorentini, C ^h   Majewski, S ⁱ   Ranki, A ^g   Proby, C M ^j   Stockfleth, E ^b   Trakatelli, M ^a   more..

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^e Sir Paul Boffa Hospital   (Malta)

^f Sir Paul Boffa Hospital ^*  (Malta)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

ⁱ MEDICAL UNIVERSITY OF WARSAW   (Poland)

^j UNIVERSITY OF DUNDEE   (United Kingdom)

^k UNIVERSITY OF LEUVEN   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAMAZEPINE; CARDIAC AGENT; CIPROFLOXACIN; DOXYCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; QUININE; RETINOID; THIAZIDE DIURETIC AGENT; THIAZINE DERIVATIVE;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FINLAND; GERMANY; GREECE; HUMAN; ITALY; LENTIGO; MAJOR CLINICAL STUDY; MALE; MALTA; MELANOCYTIC NEVUS; MELANOMA; MULTICENTER STUDY; NON MELANOMA SKIN CANCER; POLAND; PRIORITY JOURNAL; RISK FACTOR; SKIN COLOR; SPAIN; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DERMATOLOGIC AGENTS; ENVIRONMENTAL EXPOSURE; EUROPE; FEMALE; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; RISK FACTORS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84865045260     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11085.x     Document Type: Article

References (30)

1. Salasche SJ,. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: 4-7.
2. Frost C, Williams G, Green A,. High incidence and regression rates of solar keratoses in a Queensland community. J Invest Dermatol 2000; 115: 273-7.
3. Memon AA, Tomenson JA, Bothwell J, Friedmann PS,. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 2000; 142: 1154-9.
4. Naldi L, Chatenoud L, Piccitto R, et al. Prevalence of Actinic Keratoses Italian Study (PraKtis) Group. Prevalence of actinic keratoses and associated factors in a representative sample of the Italian adult population: results from the Prevalence of Actinic Keratoses Italian Study, 2003-2004. Arch Dermatol 2006; 142: 722-6.
5. Glogau RG,. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42: 23-4.
6. Gupta AK, Cooper EA, Feldman SR, et al. A survey of office visits for actinic keratosis as reported by NAMCS, 1990-1999. National Ambulatory Medical Care Survey. Cutis 2002; 70: 8-13.
7. Marks R, Rennie G, Selwood TS,. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 1: 795-7.
8. Harvey I, Frankel S, Marks R, et al. Non-melanoma skin cancer and solar keratoses, I: methods and descriptive results of the South Wales Skin Cancer Study. Br J Cancer 1996; 74: 1302-7.
9. Stockfleth E, Kerl H,. Guideline Subcommittee of the European Dermatology Forum. Guidelines for the management of actinic keratoses. Eur J Dermatol 2006; 16: 599-606.
10. Berker D, McGregor JM, Hughes BR,. British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol 2007; 156: 222-30.
11. de Vries E, Trakatelli M, Kalambalikis D, et al. Known and potential new risk factors for skin cancer in European populations, a multi-centre case-control study. Br J Dermatol 2012; 167 (Suppl. 2): 1-13.
12. Rossi R, Mori M, Lotti T,. Actinic keratosis. Int J Dermatol 2007; 46: 895-904.
13. Whiteman DC, Watt P, Purdie DM, et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003; 95: 806-12.
14. Hensen P, Muller ML, Haschemi R, et al. Predisposing factors of actinic keratosis in a North-West German population. Eur J Dermatol 2009; 19: 345-54.
15. Grossman D, Leffell DJ,. The molecular basis of nonmelanoma skin cancer. Arch Dermatol 1997; 133: 1263-70.
16. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical nevi. Eur J Cancer 2005; 41: 28-44.
17. Bataille V, Kato BS, Falchi M, et al. Nevus size and number are associated with telomere length and represent potential markers of a reduced senescence in vivo. Cancer Epidemiol Biomarkers Prev 2007; 16: 1499-502.
18. Bataille V, Grulich A, Sasieni P, et al. The association between nevi and melanoma in population with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia. Br J Cancer 1998; 77: 505-10.
19. Chang YM, Newton-Bishop JA, Bishop DT, et al. A pooled analysis of melanocytic naevus phenotype and the risk of cutaneous melanoma. Int J Cancer 2009; 124: 420-8.
20. Bataille V, Sasieni P, Grulich A, et al. Solar keratoses: a risk factor for melanoma but negative association with melanocytic nevi. Int J Cancer 1998; 78: 8-12.
21. Chang YM, Barrett JH, Bishop DT, et al. Sun exposure and melanoma risk at different latitudes. A pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol 2009; 38: 814-30.
22. Elmets CA, Viner JL, Pentland AP, et al. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst 2010; 102: 1835-44.
23. Butler GJ, Neale R, Green AC, et al. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin. J Am Acad Dermatol 2005; 53: 966-72.
24. Campbell C, Quinn AG, Ro YS, et al. P53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 1993; 100: 746-8.
25. Ren ZP, Hedrum A, Ponten F, et al. Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene 1996; 12: 765-73.
26. Einspahr JG, Xu MJ, Warneke J, et al. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses. Cancer Epidemiol Biomarkers Prev 2006; 15: 1841-8.
27. Rehman I, Quinn AG, Healy E, Rees JL,. High frequency of loss of heterozygosity in actinic keratoses, a usually benign disease. Lancet 1994; 344: 788-9.
28. Ashton KJ, Weinstein SR, Maguire DJ, Griffiths LR,. Chromosomal aberrations in squamous cell carcinoma and solar keratoses revealed by comparative genomic hybridization. Arch Dermatol 2003; 139: 876-82.
29. Green A, Battistutta D,. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer 1990; 46: 356-61.
30. Dessinioti C, Tzannis K, Sypsa V, et al. Epidemiologic risk factors of basal cell carcinoma development and age at onset in a Southern European population from Greece. Exp Dermatol 2011; 20: 622-6.